METASTATIC DIGESTIVE SYSTEM NEUROENDOCRINE NEOPLASM
Clinical trials for METASTATIC DIGESTIVE SYSTEM NEUROENDOCRINE NEOPLASM explained in plain language.
Never miss a new study
Get alerted when new METASTATIC DIGESTIVE SYSTEM NEUROENDOCRINE NEOPLASM trials appear
Sign up with your email to follow new studies for METASTATIC DIGESTIVE SYSTEM NEUROENDOCRINE NEOPLASM, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for Hard-to-Treat gut tumors: targeted pill shows promise
Disease control OngoingThis study tests a pill called abemaciclib in 20 adults with advanced digestive neuroendocrine tumors that have spread, cannot be removed by surgery, and no longer respond to standard treatments. The drug works by blocking certain enzymes that help cancer cells grow. The main goa…
Matched conditions: METASTATIC DIGESTIVE SYSTEM NEUROENDOCRINE NEOPLASM
Phase: PHASE2 • Sponsor: University of Washington • Aim: Disease control
Last updated May 17, 2026 05:08 UTC
-
New drug combo shows promise for rare gut tumors
Disease control OngoingThis early-phase trial tests a new combination of two drugs (triapine and lutetium Lu 177 dotatate) for people with advanced neuroendocrine tumors of the digestive system. The main goal is to find the safest dose and check for side effects. About 31 adults whose tumors have grown…
Matched conditions: METASTATIC DIGESTIVE SYSTEM NEUROENDOCRINE NEOPLASM
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 17, 2026 05:06 UTC
-
Promising drug shows potential to stall neuroendocrine tumors
Disease control OngoingThis study tests whether the drug cabozantinib can slow the growth of advanced neuroendocrine tumors (including carcinoid tumors) better than a placebo. About 298 adults whose cancer worsened after previous treatments will receive either cabozantinib or a dummy pill. The goal is …
Matched conditions: METASTATIC DIGESTIVE SYSTEM NEUROENDOCRINE NEOPLASM
Phase: PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 15, 2026 11:55 UTC